Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Systematic review of metformin use in obese nondiabetic children and adolescents.

Brufani C, Crinò A, Fintini D, Patera PI, Cappa M, Manco M.

Horm Res Paediatr. 2013;80(2):78-85. doi: 10.1159/000353760. Epub 2013 Jul 26. Review.

3.

Metformin for obesity in children and adolescents: a systematic review.

Park MH, Kinra S, Ward KJ, White B, Viner RM.

Diabetes Care. 2009 Sep;32(9):1743-5. doi: 10.2337/dc09-0258. Epub 2009 Jun 5. Review.

4.

Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.

Wiegand S, l'Allemand D, Hübel H, Krude H, Bürmann M, Martus P, Grüters A, Holl RW.

Eur J Endocrinol. 2010 Oct;163(4):585-92. doi: 10.1530/EJE-10-0570. Epub 2010 Jul 16.

5.

Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.

Kendall DL, Amin R, Clayton PE.

Paediatr Drugs. 2014 Feb;16(1):13-20. doi: 10.1007/s40272-013-0045-1.

PMID:
23949947
6.

Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger.

McDonagh MS, Selph S, Ozpinar A, Foley C.

JAMA Pediatr. 2014 Feb;168(2):178-84. doi: 10.1001/jamapediatrics.2013.4200. Review.

PMID:
24343296
7.

Metformin effectiveness and safety in the management of overweight/obese nondiabetic children and adolescents: metabolic benefits of the continuous exposure to metformin at 12 and 24 months.

Marques P, Limbert C, Oliveira L, Santos MI, Lopes L.

Int J Adolesc Med Health. 2016 Feb 19. pii: /j/ijamh.ahead-of-print/ijamh-2015-0110/ijamh-2015-0110.xml. doi: 10.1515/ijamh-2015-0110. [Epub ahead of print]

PMID:
26894572
8.

Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance.

Clarson CL, Mahmud FH, Baker JE, Clark HE, McKay WM, Schauteet VD, Hill DJ.

Endocrine. 2009 Aug;36(1):141-6. doi: 10.1007/s12020-009-9196-9. Epub 2009 Apr 23.

PMID:
19387874
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.

Metformin in obese children and adolescents: the MOCA trial.

Kendall D, Vail A, Amin R, Barrett T, Dimitri P, Ivison F, Kibirige M, Mathew V, Matyka K, McGovern A, Stirling H, Tetlow L, Wales J, Wright N, Clayton P, Hall C.

J Clin Endocrinol Metab. 2013 Jan;98(1):322-9. doi: 10.1210/jc.2012-2710. Epub 2012 Nov 21.

PMID:
23175691
11.

Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.

Srinivasan S, Ambler GR, Baur LA, Garnett SP, Tepsa M, Yap F, Ward GM, Cowell CT.

J Clin Endocrinol Metab. 2006 Jun;91(6):2074-80. Epub 2006 Apr 4.

PMID:
16595599
12.
13.

Treatment of clinical insulin resistance in children: a systematic review.

Quinn SM, Baur LA, Garnett SP, Cowell CT.

Obes Rev. 2010 Oct;11(10):722-30. doi: 10.1111/j.1467-789X.2009.00697.x. Review.

PMID:
20003069
14.

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.

PMID:
17680902
15.

Addition of metformin to a lifestyle modification program in adolescents with insulin resistance.

Love-Osborne K, Sheeder J, Zeitler P.

J Pediatr. 2008 Jun;152(6):817-22. doi: 10.1016/j.jpeds.2008.01.018. Epub 2008 Mar 19.

16.
17.

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ.

Hum Reprod Update. 2015 Sep-Oct;21(5):560-74. doi: 10.1093/humupd/dmv025. Epub 2015 Jun 9. Review.

PMID:
26060208
18.
19.

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.

Jones TA, Sautter M, Van Gaal LF, Jones NP.

Diabetes Obes Metab. 2003 May;5(3):163-70.

PMID:
12681023
20.

Beneficial effects of metformin in normoglycemic morbidly obese adolescents.

Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.

Metabolism. 2001 Dec;50(12):1457-61.

PMID:
11735093

Supplemental Content

Support Center